Aclaris Days Sales Outstanding from 2010 to 2025

ACRS Stock  USD 1.99  0.04  2.05%   
Aclaris Therapeutics Days Sales Outstanding yearly trend continues to be comparatively stable with very little volatility. Days Sales Outstanding will likely drop to 5.89 in 2025. From the period from 2010 to 2025, Aclaris Therapeutics Days Sales Outstanding quarterly data regression had r-value of (0.90) and coefficient of variation of  70.55. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
6.20032051
Current Value
5.89
Quarterly Volatility
44.7265344
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aclaris Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aclaris Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 942.8 K, Interest Expense of 3.2 M or Selling General Administrative of 21.5 M, as well as many indicators such as Price To Sales Ratio of 9.73, Dividend Yield of 0.0 or PTB Ratio of 0.7. Aclaris financial statements analysis is a perfect complement when working with Aclaris Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Aclaris Therapeutics Correlation against competitors.
For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.

Latest Aclaris Therapeutics' Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Aclaris Therapeutics over the last few years. It is Aclaris Therapeutics' Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aclaris Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Aclaris Days Sales Outstanding Regression Statistics

Arithmetic Mean63.39
Geometric Mean38.03
Coefficient Of Variation70.55
Mean Deviation40.92
Median104.32
Standard Deviation44.73
Sample Variance2,000
Range101
R-Value(0.90)
Mean Square Error400.79
R-Squared0.81
Slope(8.47)
Total Sum of Squares30,007

Aclaris Days Sales Outstanding History

2025 5.89
2024 6.2
2023 3.48
2022 5.94
2021 33.63
2020 43.47
2019 60.79

About Aclaris Therapeutics Financial Statements

Aclaris Therapeutics shareholders use historical fundamental indicators, such as Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Aclaris Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Aclaris Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Aclaris Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Days Sales Outstanding 6.20  5.89 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aclaris Stock Analysis

When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.